Loading
Marseille oncologist who led REGOBONE, the trial that showed regorafenib delays progression in metastatic osteosarcoma and other bone sarcomas.
Florence Duffaud is a medical oncologist at Hôpital de la Timone in Marseille and a leader of the French Sarcoma Group. She was first author of the 2019 Lancet Oncology report of the osteosarcoma cohort of REGOBONE, the randomised phase 2 trial in which regorafenib improved progression-free survival compared with placebo in metastatic osteosarcoma after chemotherapy; other cohorts studied Ewing sarcoma, chondrosarcoma and chordoma.
| Title | Journal | Year |
|---|---|---|
| Improved survival using specialized multidisciplinary board in sarcoma patients Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 274 citations on Europe PMC. | Annals of Oncology | 2017 |
| Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 267 citations on Europe PMC. | The Lancet Oncology | 2020 |
| Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 266 citations on Europe PMC. | The Lancet Oncology | 2019 |
One of the most cited papers Europe PMC returns for Florence Duffaud at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Florence Duffaud at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Florence Duffaud at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Ewing sarcoma, Osteosarcoma, Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.